Abstract
Acute i.p. administration of morphine or cocaine produced increase in locomotor activity in Swiss-Webster female mice that were maximal at 32–100 mg/kg for morphine and at 32 mg/kg for cocaine. WIN 35,197-2 produced dose-dependent decreases in locomotor activity from 3.2–32 mg/kg. Chronic administration of WIN 35,197-2 led to a 6–10 fold shift to the right in the locomotor activity decreasing effect of the drug, but WIN 35,197-2-tolerant mice retained their sensitivity to the locomotor stimulant effects of morphine and cocaine. Acute administration of WIN 35,197-2 failed to sensitize mice to naloxone-induced jumping, although morphine did so. Chronic administration of WIN 35,197-2 did lead to sensitization to naloxone, but WIN 35,197-2 was much less efficacious in this regard than morphine. These behavioral effects of WIN 35,197-2 may be helpful in the classification of modes of action of different narcotic agonists.
Similar content being viewed by others
References
Gilbert, P. E., Martin, W. R.: The effects of morphine- and nalorphine-like drugs in the nondependent, morphine-dependent, cyclazocine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 198, 66–82 (1976)
Goldstein, A., Sheehan, P.: Tolerance to opioid narcotics. I. Tolerance to the “running fit” caused by levorphanol in the mouse. J. Pharmacol. Exp. Ther. 169, 175–184 (1969)
Huidobro, F., Maggiolo, C., Contreras, E.: Studies on morphine. I. Effect on nalorphine and levallorphan in mice implanted with pellets of morphine. Arch. Int. Pharmacodyn. 144, 196–205 (1963)
Hutchinson, M., Kosterlitz, H. W., Leslie, F. M., Waterfield, A. A., Terenius, L.: Assessment in the guinea-pig ileum and mouse vas deferens of benzomorphans which have strong antinociceptive activity but do not substitute for morphine in the dependent monkey. Br. J. Pharmacol. 55, 541–546 (1975)
Jacob, J. J. C., Barthelemy, C. D., Tremblay, E. C., Colombel, M. C. L.: Potential usefulness of single-dose acute physical dependence on and tolerance to morphine for the evaluation of narcotic antagonists. Adv. Biochem. Psychopharmacol. 8, 299–318 (1974)
Kosterlitz, H. W., Waterfield, A. A.: In vitro models in the study of stucture-activity relationships of narcotic analgesics. Annu. Rev. Pharmacol. 15, 29–47 (1975)
Lord, J. A. H., Waterfield, A. A., Hughes, J., Kosterlitz, H. W.: Endogenous opioid peptides: multiple agonists and receptors. Nature 267, 495–499 (1977)
Martin, W. R., Eades, C. G., Thompson, J. A., Hyppler, R. E., Gilbert, P. E.: The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197, 517–532 (1976)
Parker, R. B.: Mouse locomotor activity: effect of morphine, narcotic antagonists, and the interaction of morphine and narcotic antagonists. Psychopharmacologia (Berl.) 38, 15–23 (1974)
Rethy, C. R., Smith, C. B., Villarreal, J. E.: Effects of narcotic analgesics upon the locomotor activity and brain catecholamine content of the mouse. J. Pharmacol. Exp. Ther. 176, 472–479 (1971)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tepper, P., Woods, J.H. Changes in locomotor activity and naloxone-induced jumping in mice produced by WIN 35,197-2 (Ethylketazocine) and morphine. Psychopharmacology 58, 125–129 (1978). https://doi.org/10.1007/BF00426894
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00426894